Albumycin, a new isoindolequinone from Streptomyces albus J1074 harboring the fluostatin biosynthetic gene cluster

J Antibiot (Tokyo). 2019 May;72(5):311-315. doi: 10.1038/s41429-019-0161-4. Epub 2019 Feb 28.

Abstract

Heterologous expression of the fluostatin biosynthetic gene cluster from the marine-derived Micromonospora rosaria SCSIO N160 in Streptomyces albus J1074 led to the isolation of a novel isoindolequinone albumycin (1) and a known isoquinolinequinone mansouramycin A (2). The structure of 1 was elucidated on the basis of detailed 1D and 2D NMR spectroscopic analysis. Mansouramycin A (2) is active against methicillin-resistant Staphylococcus aureus ATCC 43300, with a MIC of 8 μg ml-1, while albumycin (1) displayed negligible antibacterial activities. This study represents another example of activation of secondary metabolites that are non-relevant to the heterologously introduced biosynthetic gene cluster in a bacterial host.

MeSH terms

  • Anti-Bacterial Agents / isolation & purification*
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Biological Products / isolation & purification*
  • Biological Products / metabolism
  • Biological Products / pharmacology
  • Biosynthetic Pathways / genetics
  • Isoindoles / isolation & purification*
  • Isoindoles / metabolism
  • Isoindoles / pharmacology
  • Magnetic Resonance Spectroscopy
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Streptomyces / genetics
  • Streptomyces / metabolism*

Substances

  • Anti-Bacterial Agents
  • Biological Products
  • Isoindoles
  • Recombinant Proteins